Client News

Affluent Medical to attend German Fall Conference in Frankfurt in September 2024

Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update

Formycon reports a strong first half-year with multiple milestones achieved

InflaRx Reports Second Quarter 2024 Financial Results and Provides Business Update

Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers

Formycon invites to conference call on 2024 half-year results and announces participation in international investor conferences

Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results

leon-nanodrugs secures funds in a series D financing to broaden portfolio in first single-use high throughput production systems for nanoencapsulation

QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform

Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone